Aller au contenu principal
CAS 0 fiche

CAS 12004-37-4

Le CAS 12004-37-4 correspond à 0 fiche d’annexe de l’UE dans les annexes II à VI du règlement (CE) n° 1223/2009.

Fiches pour le CAS 12004-37-4

0 au total
Aucune fiche trouvée pour ce numéro CAS.

Identité et propriétés chimiques

Structure chimique 2D PubChem pour le CAS 12004-37-4
CAS 12004-37-4PubChem CID 165931

Aluminum strontium oxide (Al2SrO4)

Strontium aluminate is a chemical compound of strontium and aluminum. When activated with a suitable dopant, it acts as a photoluminescent phosphor with long persistence of phosphorescence. Aluminum is the most abundant metal in the earth's crust and is always found combined with other elements such as oxygen, silicon, and fluorine. (L739, L740, L787) — Toxin and Toxin Target Database (T3DB)

Nom IUPAC
dialuminum;distrontium;pentakis(oxygen(2-))
Formule moléculaire
Al2O5Sr2
Masse moléculaire
309.2 g/mol
Masse exacte
309.748874 Da
Surface polaire topologique
5,0 Ų
Donneurs de liaisons hydrogène
0
Accepteurs de liaisons hydrogène
5
Unités covalentes
9
Stéréocentres définis
0

Également connu sous le nom de

EINECS 234-455-3Strontium aluminic acidRefChem:111697DIALUMINIUM(3+) ION DISTRONTIUM(2+) ION PENTAOXIDANDIIDEstrontium aluminatedialuminum;distrontium;oxygen(2-)strontium;oxido(oxo)alumaneFNWBQFMGIFLWII-UHFFFAOYSA-N

Preuves issues de bases de données scientifiques complémentaires

NIH PubChem PUG-View
Correspondance exacte d’identifiant165931

Attributed physical-property, hazard, environmental and use annotations.

  • Carcinogen Classification: Not listed by IARC. IARC classified aluminum production as carcinogenic to humans (Group 1), but did not implicate aluminum itself as a human carcinogen. (L135) A link between use of aluminum-containing antiperspirants and increased risk of breast cancer has been proposed (A235), but studies have not been able to establish a clear link (A15468). Source: Toxin and Toxin Target Database (T3DB)
  • Note: This chemical does not meet GHS hazard criteria for 5.1% (10 of 195) of reports. Source: European Chemicals Agency (ECHA)
  • Signal: Warning Source: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H315 (94.9%): Causes skin irritation [Warning Skin corrosion/irritation]; H319 (94.9%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H335 (94.9%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation] Source: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement) Source: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 195 reports by companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 10 of 195 reports by companies.; There are 6 notifications provided by 185 of 195 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. Source: European Chemicals Agency (ECHA)
  • Health Effects: Aluminum targets the nervous system and causes decreased nervous system performance and is associated with altered function of the blood-brain barrier. The accumulation of aluminum in the body may cause bone or brain diseases. High levels of aluminum have been linked to Alzheimer's disease. A small percentage of people are allergic to aluminium and experience contact dermatitis, digestive disorders, vomiting or other symptoms upon contact or ingestion of products containing aluminium. (L739, L740) Source: Toxin and Toxin Target Database (T3DB)
  • Toxicity Summary: The main target organs of aluminum are the central nervous system and bone. Aluminum binds with dietary phosphorus and impairs gastrointestinal absorption of phosphorus. The decreased phosphate body burden results in osteomalacia (softening of the bones due to defective bone mineralization) and rickets. Aluminum's neurotoxicity is believed to involve several mechanisms. Changes in cytoskeletal protein functions as a results of altered phosphorylation, proteolysis, transport, and synthesis are believed to be one cause. Aluminum may induce neurobehavioral effects by affecting permeability of the blood-brain barrier, cholinergic activity, signal transduction pathways, lipid peroxidation, and impair neuronal glutamate nitric oxide-cyclic GMP pathway, as well as interfere with metabolism of essential trace elements because of similar coordination chemistries and consequent competitive interactions. It has been suggested that aluminum's interaction with estrogen receptors increases the expression of estrogen-related genes and thereby contributes to the progression of breast cancer (A235), but studies have not been able to establish a clear link between aluminum and increased risk of brea Source: Toxin and Toxin Target Database (T3DB)
  • Uses: When activated with a suitable dopant, strontium aluminate acts as a photoluminescent phosphor with long persistence of phosphorescence. (L787) Source: Toxin and Toxin Target Database (T3DB)

Mis en correspondance par: Existing checksum-valid CAS to unique PubChem CID match. Récupéré le: 2026-08-31. Ouvrir la fiche source

Les classifications scientifiques et les annotations de danger apportent du contexte et ne remplacent pas la décision réglementaire propre au marché indiquée ci-dessus.

Couverture des sources complémentaires et état des correspondances
SourceRésultatVérifié
NIH PubChem PUG-ViewCorrespondance exacte2026-08-31

Une absence de correspondance enregistrée est une preuve utile que la source a été vérifiée ; ce n’est pas l’affirmation que la substance n’existe pas ailleurs.

Récupéré depuis NIH PubChem le 2026-08-31 par correspondance CAS à somme de contrôle valide. Les propriétés chimiques ne remplacent pas la décision réglementaire de cette page.

Comment le CAS 12004-37-4 est utilisé sur ce site

Le CAS 12004-37-4 est l’identifiant du Chemical Abstracts Service utilisé pour rattacher cette page à une substance précise. Dans le jeu de données actuel, 0 fiche d’annexe de l’UE partage cet identifiant, ce qui vous aide à vérifier si la même substance apparaît dans un seul contexte réglementaire ou dans plusieurs.

Utilisez cette page lorsqu’une spécification fournisseur, une FDS ou un dossier de matière première vous donne le CAS 12004-37-4 et que vous devez voir au même endroit toutes les fiches liées des annexes II à VI. Les cartes d’entrées ci-dessus sont le moyen le plus rapide d’accéder aux limites de concentration, aux avertissements, à l’annexe concernée et aux conditions par type de produit.